Kezar Life Sciences, Inc. (KZR) Deferred Tax Assets, Valuation Allowance USD 2016 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Kezar Life Sciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2016 to 2023.
  • Kezar Life Sciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $82.5 M, a 44.9% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $82.5 M +$25.6 M +44.9% Dec 31, 2023 10-K 2024-03-14
Q4 2022 $57 M +$15.2 M +36.4% Dec 31, 2022 10-K 2024-03-14
Q4 2021 $41.8 M +$12.4 M +42% Dec 31, 2021 10-K 2023-03-14
Q4 2020 $29.4 M +$9.21 M +45.6% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $20.2 M +$7.64 M +60.8% Dec 31, 2019 10-K 2022-03-17
Q4 2018 $12.6 M +$5.13 M +69% Dec 31, 2018 10-K 2021-03-11
Q4 2017 $7.43 M +$398 K +5.66% Dec 31, 2017 10-K 2020-03-12
Q4 2016 $7.04 M Dec 31, 2016 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.